Tuberculosis immune reconstitution syndrome (TB-IRIS) followed by recurring lymphadenitis up to 8 years post-antituberculous treatment.
Ole Skouvig PedersenTrine Ørhøj BarkholtStine Horskær MadsenFrauke RudolfPublished in: BMJ case reports (2024)
We present the case of a patient with HIV and tuberculosis (TB) coinfection who initially developed paradoxical TB immune reconstitution inflammatory syndrome (TB-IRIS) post-antituberculous treatment and post-antiretroviral therapy initiation. Despite being managed effectively, lymphadenitis recurred as many as three times over the course of several years. Due to consistent culture-negative lymph node biopsies, the recurring lymphadenitis was eventually deemed inflammatory rather than microbiological recurrences. Cessation of anti-TB treatment led to symptom remission followed by a long asymptomatic period, corroborating the immunological nature of the episodes. However, 5 and 6 years after cessation of anti-TB treatment, respectively, lymphadenitis returned. In both instances, her symptoms regressed without treatment with anti-TB drugs. This case underscores the complexities of managing TB-IRIS and the necessity of differentiating between paradoxical TB-IRIS and other paradoxical reactions for appropriate treatment decisions. Recognition of such distinctions is crucial in guiding effective therapeutic interventions in TB-HIV coinfection scenarios.
Keyphrases
- mycobacterium tuberculosis
- antiretroviral therapy
- lymph node
- emergency department
- squamous cell carcinoma
- magnetic resonance imaging
- physical activity
- oxidative stress
- climate change
- rheumatoid arthritis
- depressive symptoms
- radiation therapy
- combination therapy
- disease activity
- smoking cessation
- south africa
- patient reported